Issued & Outstanding: 86,106,361 and Reserved for Issuance: 32,025,804. There is probably 20% or likely more, tightly held by insiders, large loyal shareholders and certain other stakeholders. The Reserved for issuance number will be reduced very soon as we are introducing a warrant incentive program to encourage shareholders to exercise their warrants at a much lower price, and there are warrants and options that expire soon as well.
Well here we are … at the elevator on the main floor. I always refer to this as the elevator pitch moment but someone asked me recently when I was speaking at an engagement what that meant. We all take for granted these terms are just known. So … as you step on to the elevator a young investor steps on with you and sees your lanyard and ID badge. You push floor 10 and she floor 9. She asks you why she should invest in Alliance. In the 9 floors you have … why should she as well as others look to Alliance?
elements. Can you bring our readers to speed on your current net and fully diluted shares outstanding …. And from there, about what % would be tightly held by insiders etc … the residual being the effective public float?
Alliance is unique in that its flagship project, the Cannabis Biotech complex sells to the LP industry with insignificant competition and we have realistic international projects as a low-cost producer in the medical cannabis space with ready customers. Also, with access to the proprietary hemp strain “CBD DANA”, along with experienced strategic partners in Nevada, we are poised for success in the hemp space as well.
116